230 likes | 466 Views
Anaphylaxis. Lucy Walker 27 th February 2013. Curriculum Requirements. 2.14 Management of Emergencies in Palliative Medicine: “To have the knowledge, understanding and skills to manage emergencies in Palliative Medicine”: Management of Anaphylaxis. Aims.
E N D
Anaphylaxis Lucy Walker 27th February 2013
Curriculum Requirements • 2.14 Management of Emergencies in Palliative Medicine: “To have the knowledge, understanding and skills to manage emergencies in Palliative Medicine”: • Management of Anaphylaxis
Aims • To provide an overview of the investigation and management of anaphylaxis; • To revise the Resus Council algorithm; • To highlight the key recommendations in the NICE guidelines
Learning Objectives • By the end of the session, you will be able to: • identify a patient with anaphylaxis • confidently list the drugs and doses involved in the management of anaphylaxis • send Mast Cell Tryptase tests
True or False: PART ONE • The UK incidence of anaphylactic reactions is increasing • Patients with asthma are at a higher risk of anaphylaxis • Adrenaline should be given with a green needle • There is a 5% fatality rate from anaphylaxis • Adrenaline should be given at half the recommended dose in patients who are taking Tricyclics • Nuts are the commonest cause of fatal anaphylaxis in the UK • Skin or mucosal changes alone can indicate anaphylaxis • All fatal cases of anaphylaxis should be discussed with the coroner • Patients should be monitored for at least 24 hours after anaphylaxis • It is important to find and remove the stinger is a suspected anaphylaxis due to insect sting
Definitions • “Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction” • Immunologically (IgE) mediated/ allergic • Non-immunologically mediated • Idiopathic
Mast Cell Tryptase • Tryptase is a major protein component of mast cell secretory granules; • Useful in follow up of suspected anaphylaxis rather than initial diagnosis; • Must record time of onset of symptoms; • Minimum- one sample 1-2 hours post onset • Ideally- three samples (as soon as resus starts, 1-2 hrs after symptom onset, at 24 hours/ in allergy follow up clinic)
Monitoring Period • Beware of the Biphasic reaction • Observe for at least 6 hours in a place with facilities to deal with life threatening ABC problems. • Further medical review prior to discharge. • Keep high risk patients for up to 24 hours • Consider 3 days of steroid and anti-histamine
Follow Up • All patients presenting with anaphylaxis should be referred to an allergy clinic • Patient Education • Offer an adrenaline auto-injector (and advice about how and when to use it) • ?Anaphylactic reactions to drugs should be reported with a yellow card.
True or False: • A chance to change…
True or False: PART TWO • TRUE: • The UK incidence of anaphylactic reactions is increasing • Patients with asthma are at a higher risk of anaphylaxis • All fatal cases of anaphylaxis should be discussed with the coroner • It is important to find and remove the stinger is a suspected anaphylaxis due to insect sting
True or False: PART TWO • FALSE: • Adrenaline should be given with a green needle • There is a 5% fatality rate from anaphylaxis • Adrenaline should be given at half the recommended dose in patients who are taking Tricyclics • Nuts are the commonest cause of fatal anaphylaxis in the UK • Skin or mucosal changes alone can indicate anaphylaxis • Patients should be monitored for at least 24 hours after anaphylaxis
Take Home Messages • Ensure an A, B or C problem in addition to any skin or mucosal changes to make diagnosis • Safest to treat if these criteria are fullfilled • Adrenaline (1 in 1000) 500 micrograms IM and repeat at 5 minute intervals if needed • Remember Mast Cell Tryptase and specialist referral in appropriate patients
References • Resuscitation Council UK (2008) Emergency treatment of anaphylactic reactions (www.resus.org.uk). London: Resuscitation Council (UK) • National Institute for Health and Clinical Excellence (2011) Anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode [CG134]. London: National Institute for Health and Clinical Excellence